Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Evan Loh

Affiliations

  • Ceo at Paratek Pharmaceuticals Inc. (PRTK), 2019-10-09
  • Director at Eiger Biopharmaceuticals Inc. (EIGR), 2019-03-26
  • Director at Nivalis Therapeutics Inc. (NVLS), 2016-09-14
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PRTK $16.67 900 Officer, Director 80,389 2015-12-11 Filing
PRTK $17.00 1,400 Officer, Director 79,489 2015-12-10 Filing
PRTK $16.16 3,700 Officer, Director 78,089 2015-11-16 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PRTK $3.82 7,818 Officer, Director 432,117 2019-10-08 Filing
PRTK $3.98 16,265 Officer, Director 413,935 2019-10-03 Filing
PRTK $6.27 6,000 Officer, Director 277,700 2018-12-13 Filing
PRTK $6.76 5,525 Officer, Director 283,700 2018-12-12 Filing
PRTK $8.96 5,200 Officer, Director 289,225 2018-10-15 Filing